Nippon India Pharma Fund Direct

Fund Name : Nippon India Mutual Fund
Scheme Name : Nippon India Pharma Fund Direct
AMC : Nippon India Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 10-May-04
Fund Manager : Sailesh Raj Bhan
Net Assets (Rs. cr) : 3910.67

Nippon India Pharma Fund Direct - NAV Details

NAV Date : 23-Nov-20
NAV [Rs.] : 73.73
Buy/Resale Price [Rs.] : 0
Sell/Repurchase Price [Rs.] : 0
Entry Load % : Nil
Exit Load % : Nil

Nippon India Pharma Fund Direct - NAV Chart

Nippon India Pharma Fund Direct - Performance(%)

* returns above 1 yr. are annualized
  1w 1m 3m 6m 1y 3y 5y Since INC
Scheme Returns 2.17 4.37 5.15 27.12 54.12 19.12 9.28 20.92
Category Avg [0.08] 0.45 4.20 28.02 53.28 16.86 7.59 21.97
Category Best 0.24 1.76 7.64 39.70 68.87 20.17 10.23 37.49
Category Worst [0.33] [0.55] 2.18 21.75 42.16 12.22 4.23 6.56

Nippon India Pharma Fund Direct - Latest Dividends

  Dividends Bonus
Ratio 39.84 NA
Date 2/24/2020 12:00:00 AM 2/24/2020 12:00:00 AM

Nippon India Pharma Fund Direct - Investment Details

Min. Investment(Rs.) : 5000
Increm.Investment(Rs.) : 1

In & Out

In
Name of the Company No of shares
No Data Found
Out
Name of the Company No of shares
No Data Found

Fund Holdings

Asset Type Instrument Name Industry Net Assets(%) No of Shares Mkt Value(Cr.)
Equity & Equity related Investments
Equity Divi's Lab. Pharmaceuticals 9.67 1,200,075.00 377.07
Equity Sun Pharma.Inds. Pharmaceuticals 9.56 8,000,976.00 372.65
Equity Aurobindo Pharma Pharmaceuticals 9.33 4,710,000.00 363.92
Equity Cipla Pharmaceuticals 9.09 4,700,000.00 354.62
Equity Lupin Pharmaceuticals 8.86 3,800,025.00 345.52
Equity Dr Reddy's Labs Pharmaceuticals 7.52 600,000.00 293.32
Equity Thyrocare Tech. Healthcare Services 6.84 2,323,279.00 266.88
Equity Cadila Health. Pharmaceuticals 5.09 4,748,982.00 198.37
Equity Fortis Health. Healthcare Services 4.64 14,403,541.00 180.91
Equity Apollo Hospitals Healthcare Services 4.41 811,506.00 171.99
Equity Sanofi India Pharmaceuticals 3.59 175,000.00 140
Equity Narayana Hrudaya Healthcare Services 3.51 4,000,881.00 136.81
Equity Abbott India Pharmaceuticals 3.31 84,371.00 129.07
Equity Biocon Pharmaceuticals 2.28 2,203,178.00 88.92
Equity Indoco Remedies Pharmaceuticals 2.23 3,390,190.00 87.08
Equity Shilpa Medicare Pharmaceuticals 1.44 1,250,000.00 55.98
Equity Alkem Lab Pharmaceuticals 1.42 209,570.00 55.21
Equity Syngene Intl. Pharmaceuticals 1.39 1,012,877.00 54.18
Equity Torrent Pharma. Pharmaceuticals 1.32 200,000.00 51.34
Equity Pfizer Pharmaceuticals 0.67 52,746.00 26.29
Equity Health.Global Healthcare Services 0.36 1,162,723.00 13.96
 
Derivative Investments
Derivatives Derivatives -/- 0.32 0.00 12.35
 
Cash & Cash Equivalent
Reverse Repo TREPS -/- 4.56 0.00 177.73
Cash & Cash Equivalent Cash & Cash Equivalent -/- 0 0.00 0.05
Net CA & Others Net CA & Others -/- [1.41] 0.00 [54.52]
 
 
Fund Manager Speak

 

My wealth at retirement

Calculate the worth of your wealth at retirement

My age (years)
Age I plan to retire (years)
Current savings (Rs.)
Monthly savings (Rs.)
ROI(% p.a.)
Key Information
Fund House : Nippon India Mutual Fund
Incorporation Date : 24-Feb-1995
Total Assets Managed (Cr.) : 201,301.77
Trustee/s : Nippon Life India Trustee
Chairman : N/A
CEO / MD : Mr. Sundeep Sikka
CIO : N/A
President : N/A
Director/s : Mr. Takayuki Murai
Compliance Officer/s : Mr. Muneesh Sud
Investor Service Officer/s : Mr. Bhalchandra Joshi
Fund Manager/s : Sailesh Raj Bhan
Other Information
Auditors : N/A
Registered Office : 4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos : 022-68087000
Fax : 022-68087097
Email : customercare@nipponindiamf.com
Website : www.nipponindiamf.com

Mutual Funds News